Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate 68462-0653-01
- Manufacturer
- Glenmark Pharmaceuticals Inc., Usa
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- May 12, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA210754
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Dl-Aspartate | 7.5 mg/1 |
| Amphetamine Sulfate | 7.5 mg/1 |
| Dextroamphetamine Saccharate | 7.5 mg/1 |
| Dextroamphetamine Sulfate | 7.5 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Selected Package
68462-0653-01Selected100 TABLET in 1 BOTTLE (68462-653-01)